Compare TWST & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | AMLX |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2018 | 2022 |
| Metric | TWST | AMLX |
|---|---|---|
| Price | $46.04 | $14.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $47.89 | $17.43 |
| AVG Volume (30 Days) | 1.4M | ★ 1.8M |
| Earning Date | 02-02-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $391,557,000.00 | N/A |
| Revenue This Year | $16.77 | N/A |
| Revenue Next Year | $15.06 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.59 | N/A |
| 52 Week Low | $23.30 | $2.60 |
| 52 Week High | $54.74 | $17.49 |
| Indicator | TWST | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 69.16 | 52.85 |
| Support Level | $39.66 | $14.04 |
| Resistance Level | $43.34 | $15.79 |
| Average True Range (ATR) | 2.50 | 1.19 |
| MACD | 0.16 | -0.06 |
| Stochastic Oscillator | 77.41 | 38.37 |
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.